Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Observational
Started
2025-01-01
Last updated
2025-01-31
Condition(s) studied
Atrial Fibrillation (AF)
Investigational drug(s) / intervention(s)
catheter ablation, left atrial appendage closure
catheter ablation, left atrial appendage closure: Compare the clinical prognosis of patients with AF underwent the combined procedure of catheter ablation and left atrial appendage closure (LAAC), single catheter ablation and single LAAC.
Study summary
Using the Shanghai Municipal Health Commission database and Shanghai Centers for Disease Control and Prevention database, patients with AF in Shanghai are included to construct the Shanghai AF registry to investigate clinical characteristics, treatment, and prognosis.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* With diagnosis of AF: the diagnosis must be identified from the Shanghai Municipal Health Commission database and verified by 12-lead ECG or Holter monitoring since 2015
* Residents of Shanghai
* Taking part in the government-issued health insurance, including the Urban Residents' Basic Medical Insurance (URBMI), the Urban-Employ Based Medical Insurance (UEBMI) and the New Rural Cooperative Medical Scheme (NRCMS).
Exclusion Criteria:
* Non-residence of Shanghai
* Without the government-issued health insurance
* Die at the day of index diagnosis of AF
Primary outcome measure(s)
Composite of death, ischemic stroke, systemic embolism, myocardial infarction, major bleeding, and acute heart failure — From enrollment to December 31, 2024 Composite of death, ischemic stroke, systemic embolism, myocardial infarction, major bleeding, and acute heart failure
Trial sites (1)
Facility
City
Region
Status
Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai
China
More Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.